三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > 图8奥雷巴替尼临床获益以及耐受性情况
图片属性
图片格式：PNG 图片大小：1367KB 图片尺寸：2306*1351
同报告图片
 / 4
图8奥雷巴替尼临床获益以及耐受性情况_第1页
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
图8奥雷巴替尼临床获益以及耐受性情况_第2页
图8奥雷巴替尼临床获益以及耐受性情况_第3页
5aW955qE77yM5Lul5LiL5piv5oKo5o+Q5L6b55qE5Zu+54mH5pWw5o2u55Sf5oiQ55qE6KGo5qC877yM5bm25Zyo6KGo5qC85LiL5pa55bGV56S65LqG6LWE5paZ5p2l5rqQ77yaCgp8IOmhueebriAgICAgICAgICAgICAgIHwgMjAyNEEgIHwgMjAyNUUgIHwgMjAyNkUgIHwgMjAyN0UgIHwgMjAyOEUgICB8IDIwMjlFICAgfCAyMDMwRSAgIHwgMjAzMUUgICB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLS0tLXwtLS0tLS0tLS18CnwgRUJJVCAgICAgICAgICAgICAgIHwgLTMzMC44MHwgLTU3NC4zNXwgOTMxLjIzIHwgLTE3Ni40NHwgNDIuNzkgICB8IDEsMTgxLjQxfCAyLDYyMS45MnwgNCw2OTUuNTF8Cnwg5omA5b6X56iO546HICAgICAgICAgICB8IDAuMDAlICB8IDAuMDAlICB8IDAuMDAlICB8IDE1LjAwJSB8IDE1LjAwJSAgfCAxNS4wMCUgIHwgMTUuMDAlICB8IDE1LjAwJSAgfAp8IOaBr+WJjeeojuWQjuWIqea2pihOT1BBVCl8IC0zMzAuODB8IC01NzQuMzV8IDkzMS4yMyB8IC0xNDkuOTd8IDM2LjM3ICAgfCAxLDAwNC4yMHwgMiwyMjguNjR8IDMsOTkxLjE4fAp8IOWKoO+8mumdnueOsOmHkeiwg+aVtCAgICAgfCA5My4xNyAgfCA4LjQ3ICAgfCA4LjMzICAgfCA4LjIwICAgfCA4LjA3ICAgIHwgNy45NCAgICB8IDcuODEgICAgfCA3LjY4ICAgIHwKfCDlh4/vvJrokKXov5DotYTph5HnmoTlop7liqB8IDIwNS4xNSB8IC0xNi44NCB8IDMuOTIgICB8IC0zOC44NiB8IC0xLDI1NS42MXwgLTk3MS41MiB8IC0xLDUxMi41NHwgLTEsOTU0Ljg4fAp8IOWHj++8mui1hOacrOaAp+aKlei1hCAgICAgfCAtMjQuMjkgfCA1LjAwICAgfCA1LjAwICAgfCA1LjAwICAgfCA1LjAwICAgIHwgNS4wMCAgICB8IDUuMDAgICAgfCA1LjAwICAgIHwKfCDlhazlj7joh6rnlLHnjrDph5HmtYHph49GQ0ZGfCAtNDY3LjA3fCAtNTQ0LjA0fCA5NDAuNjQgfCAtOTcuOTEgfCAxLDMwNS4wNXwgMSw5ODguNjZ8IDMsNzUzLjk5fCA1LDk1OC43NXwKCui1hOaWmeadpea6kO+8mndpbmTvvIzljY7opb/or4HliLjnoJTnqbbmiYA=
图8奥雷巴替尼临床获益以及耐受性情况_第4页
图8奥雷巴替尼临床获益以及耐受性情况_第5页
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
所属报告： 亚盛医药~B-港股公司研究报告-具有全球化视野的血液瘤创新药企-250626（25页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询网站充值下载问题
copyright@2008-2013 长沙景略智创信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备17000430号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠